To study the outcomes of women with infertility or miscarriage treated with natural procreative technology (NaProTechnology or NPT), a systematic medical approach to promoting conception in vivo; and to compare the outcomes with those previously published from a general practice in Ireland.
Design
Retrospective cohort study.
Setting
An urban Canadian primary care practice in which the physician had a part-time practice in NPT.
Participants
Couples with infertility or recurrent miscarriage who received treatment in the practice between August 2000 and July 2006.
Intervention
All couples were taught to identify the fertile time of their menstrual cycles using the Creighton Model FertilityCare System (CrMS) and completed a standard NPT evaluation. Many also received additional medical treatment to enhance conception in vivo.
Main Outcome Measures
Live birth was the primary outcome; secondary outcomes included conceptions, multiple births, low birth weight, and prematurity.
Results
A total of 108 couples received NPT and were included in the analysis, of which 19 (18%) reported having 2 or more previously unexplained miscarriages. The average female age was 35.4 years. Couples had been attempting to conceive for a mean of 3.2 years. Twentytwo participants (20%) had previously given birth; 24 (22%) had previous intrauterine insemination; and 9 (8%) had previous assisted reproductive technology. The cumulative adjusted proportion of first live births for those completing up to 24 months of NPT treatment was 66 per 100 couples, and the crude proportion was 38%. The cumulative adjusted proportion of first conceptions was 73 per 100 couples, and the crude proportion was 47%. Of the 51 couples who conceived, 12 couples (24%) conceived with CrMS instruction alone, 35 (69%) conceived with CrMS and NPT medical treatment, and 4 (8%) conceived after additional surgical treatment. All births were singleton births; 54% were born at 37 weeks' gestation or later; and 78% had birth weights of 2500 g or greater.
Conclusion
Natural procreative technology in a family physician's office was effective in treating infertility and miscarriage with outcomes that were comparable to those in an NPT general practice in Ireland. Larger multicentre prospective studies to compare NPT directly to other forms of infertility treatment are warranted.
NaProTechnology infertility outcomes, natural procreative technology miscarriage, recurrent miscarriage NaProTechnology, Creighton Model fertility outcomes, progesterone support pregnancy, NaPro live birth rate, infertility treatment without IVF, cervical mucus monitoring NaPro, hormonal support early pregnancy, NaProTechnology vs IVF outcomes
PMID 22734170 22734170 DOI 10.46747/cfp.5805e267 10.46747/cfp.5805e267
Cite this article
Tham, E., Schliep, K., & Stanford, J. (2012). Natural procreative technology for infertility and recurrent miscarriage: outcomes in a Canadian family practice. *Canadian Family Physician Medecin De Famille Canadien*, *58*(5), e267-74. https://doi.org/10.46747/cfp.5805e267
Tham E, Schliep K, Stanford J. Natural procreative technology for infertility and recurrent miscarriage: outcomes in a Canadian family practice. Can Fam Physician. 2012;58(5):e267-74. doi:10.46747/cfp.5805e267
Tham, E., et al. "Natural procreative technology for infertility and recurrent miscarriage: outcomes in a Canadian family practice." *Canadian Family Physician Medecin De Famille Canadien*, vol. 58, no. 5, 2012, pp. e267-74.
Objective Complicated grief reactions follow some pregnancy outcomes, like miscarriage, stillbirth, neonatal death, infant death, selective reduction, or termination of pregnancy. Stigma can delay tre...
Schliep KC et al., 2022Human Reproduction (Oxford, England)
STUDY Question: What is the association between perceived stress during peri-conception and early pregnancy and pregnancy loss among women who have experienced a prior pregnancy loss?
SUMMARY ANSWER:...
Sanders JN et al., 2022
Open Access
Reproductive Health
Background: In vitro fertilization (IVF) births contribute to a considerable proportion of preterm birth (PTB) each year. However, there is no formal surveillance of adverse perinatal outcomes for les...
Kuroda K et al., 2021
Open Access
Reproductive Medicine and Biology
Purpose: Does the OPtimization of Thyroid function, Thrombophilia, Immunity, and Uterine Milieu (OPTIMUM) treatment strategy, developed for treating repeated implantation failure (RIF), contribute to ...